328 related articles for article (PubMed ID: 26479335)
1. Therapeutic targets for cholestatic liver injury.
Woolbright BL; Jaeschke H
Expert Opin Ther Targets; 2016; 20(4):463-75. PubMed ID: 26479335
[TBL] [Abstract][Full Text] [Related]
2. Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents.
Yu D; Cai SY; Mennone A; Vig P; Boyer JL
Liver Int; 2018 Jun; 38(6):1128-1138. PubMed ID: 29356312
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of bile acid mediated inflammation in the liver.
Li M; Cai SY; Boyer JL
Mol Aspects Med; 2017 Aug; 56():45-53. PubMed ID: 28606651
[TBL] [Abstract][Full Text] [Related]
4. Bile Acids in Cholestasis and its Treatment.
Arab JP; Cabrera D; Arrese M
Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s53-s57. PubMed ID: 29080340
[TBL] [Abstract][Full Text] [Related]
5. Conditional loss of geranylgeranyl diphosphate synthase alleviates acute obstructive cholestatic liver injury by regulating hepatic bile acid metabolism.
Jia WJ; Tang QL; Jiang S; Sun SQ; Xue B; Qiu YD; Li CJ; Mao L
FEBS J; 2020 Aug; 287(15):3328-3345. PubMed ID: 31905247
[TBL] [Abstract][Full Text] [Related]
6. Inflammation and Cell Death During Cholestasis: The Evolving Role of Bile Acids.
Woolbright BL; Jaeschke H
Gene Expr; 2019 Nov; 19(3):215-228. PubMed ID: 31253204
[TBL] [Abstract][Full Text] [Related]
7. A novel murine model of reversible bile duct obstruction demonstrates rapid improvement of cholestatic liver injury.
Taylor SA; Yeap XY; Wang JJ; Gromer KD; Kriegermeier A; Green RM; Zhang ZJ
Physiol Rep; 2020 May; 8(10):e14446. PubMed ID: 32441483
[TBL] [Abstract][Full Text] [Related]
8. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory, anti-oxidative stress and novel therapeutic targets for cholestatic liver injury.
Zhang Y; Lu Y; Ji H; Li Y
Biosci Trends; 2019 Mar; 13(1):23-31. PubMed ID: 30814402
[TBL] [Abstract][Full Text] [Related]
10. Inflammation: Cause or consequence of chronic cholestatic liver injury.
Woolbright BL
Food Chem Toxicol; 2020 Mar; 137():111133. PubMed ID: 31972189
[TBL] [Abstract][Full Text] [Related]
11. Farnesoid X receptor modulators (2011 - 2014): a patent review.
Sepe V; Distrutti E; Fiorucci S; Zampella A
Expert Opin Ther Pat; 2015; 25(8):885-96. PubMed ID: 26183029
[TBL] [Abstract][Full Text] [Related]
12. Early growth response factor-1 is critical for cholestatic liver injury.
Kim ND; Moon JO; Slitt AL; Copple BL
Toxicol Sci; 2006 Apr; 90(2):586-95. PubMed ID: 16423862
[TBL] [Abstract][Full Text] [Related]
13. Endogenous glucocorticoids exacerbate cholestasis-associated liver injury and hypercholesterolemia in mice.
van der Geest R; Ouweneel AB; van der Sluis RJ; Groen AK; Van Eck M; Hoekstra M
Toxicol Appl Pharmacol; 2016 Sep; 306():1-7. PubMed ID: 27374722
[TBL] [Abstract][Full Text] [Related]
14. Lithocholic acid feeding results in direct hepato-toxicity independent of neutrophil function in mice.
Woolbright BL; Li F; Xie Y; Farhood A; Fickert P; Trauner M; Jaeschke H
Toxicol Lett; 2014 Jul; 228(1):56-66. PubMed ID: 24742700
[TBL] [Abstract][Full Text] [Related]
15. Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis.
Allen K; Jaeschke H; Copple BL
Am J Pathol; 2011 Jan; 178(1):175-86. PubMed ID: 21224055
[TBL] [Abstract][Full Text] [Related]
16. IL-17A synergistically enhances bile acid-induced inflammation during obstructive cholestasis.
O'Brien KM; Allen KM; Rockwell CE; Towery K; Luyendyk JP; Copple BL
Am J Pathol; 2013 Nov; 183(5):1498-1507. PubMed ID: 24012680
[TBL] [Abstract][Full Text] [Related]
17. Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response.
Cai SY; Ouyang X; Chen Y; Soroka CJ; Wang J; Mennone A; Wang Y; Mehal WZ; Jain D; Boyer JL
JCI Insight; 2017 Mar; 2(5):e90780. PubMed ID: 28289714
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol effectively attenuates α-naphthyl-isothiocyanate-induced acute cholestasis and liver injury through choleretic and anti-inflammatory mechanisms.
Wang T; Zhou ZX; Sun LX; Li X; Xu ZM; Chen M; Zhao GL; Jiang ZZ; Zhang LY
Acta Pharmacol Sin; 2014 Dec; 35(12):1527-36. PubMed ID: 25418378
[TBL] [Abstract][Full Text] [Related]
19. Novel insight into mechanisms of cholestatic liver injury.
Woolbright BL; Jaeschke H
World J Gastroenterol; 2012 Sep; 18(36):4985-93. PubMed ID: 23049206
[TBL] [Abstract][Full Text] [Related]
20. Bile acids and their receptors: modulators and therapeutic targets in liver inflammation.
Bertolini A; Fiorotto R; Strazzabosco M
Semin Immunopathol; 2022 Jul; 44(4):547-564. PubMed ID: 35415765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
